TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH

OCTOBER 01, 2006
Anna D. Garrett, PharmD, BCPS, CPP

Patients who experience transient ischemic attacks (TIAs) are at high risk for stroke and need preventive therapy. Aspirin is commonly used to reduce the risk of stroke in these patients. Some patients, however, may continue to experience TIAs while on aspirin therapy. Data regarding the efficacy of other antiplatelet therapies such as dipyridamole, ticlopidine, or clopidogrel in combination with aspirin are limited.

The American Heart Association recognizes the lack of evidence in this area. It recommends therapy be individualized for each patient to receive either the combination of extended-release dipyridamole and aspirin or clopidogrel 75 mg daily for secondary prevention. Clopidogrel is recommended over ticlopidine because it has a better safety profile.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.




SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.